MedTrace Logo

Effects of Pilates and Desk-Based Exercise on Office Workers

NCT07763925 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2026-08-13

No results posted yet for this study

Summary

This study evaluated whether adding Pilates exercises to a desk-based exercise program provides greater benefits for female office workers than desk-based exercises alone or no exercise intervention. The study included 42 female office workers who were randomly assigned to three groups: a desk-based exercise group, a combined desk-based exercise and Pilates group, or a control group. The exercise interventions were performed for 6 weeks, three days per week. Pain, posture, core muscle endurance, burnout, and hedonic eating behavior were assessed before and after the intervention.

Conditions

Interventions

BEHAVIORAL

Desk-Based Exercise

A workplace-adapted desk-based exercise program consisting of 13 exercises, with 10 repetitions of each exercise, designed to reduce musculoskeletal complaints in office workers, particularly in the shoulder, neck, and low back regions. The program was performed for 6 weeks, three days per week.

BEHAVIORAL

Pilates

A mat-based Pilates exercise program using body weight as resistance. Each 60-minute session consisted of a 10-minute warm-up, 40-minute main exercise period, and 10-minute cool-down. Exercise difficu

Sponsors & Collaborators

  • Muharrem Gökhan Beydağı

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
24 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-15
Primary Completion
2025-04-20
Completion
2025-04-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07763925 on ClinicalTrials.gov